Future directions of myocardial fatty acid imaging

Journal of Nuclear Cardiology

Volumn 14, Issue 3 SUPPL., 2007, Pages

  Pastore, Christopher J ^a   Babich, John W ^b   Udelson, James E ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; 15 (4 IODOPHENYL)PENTADECANOIC ACID I 123; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; DICHLOROACETIC ACID; DOBUTAMINE; FATTY ACID; FATTY ACID DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; RANOLAZINE; TECHNETIUM 99M; TETROFOSMIN; TETROFOSMIN TC 99M; THALLIUM; THALLIUM 201;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; ISOTOPE LABELING; LOW DRUG DOSE; NON INVASIVE PROCEDURE; OXYGEN CONSUMPTION; OXYGEN SUPPLY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; THORAX PAIN;

CARDIOMYOPATHIES; FATTY ACIDS; HEART; HUMANS; MYOCARDIUM; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY;

EID: 34249725470     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.02.013     Document Type: Article

References (52)

1. Taegtmeyer H., King L.M., and Jones B.E. Energy substrate metabolism, myocardial ischemia, and targets for pharmacotherapy. Am J Cardiol 82 (1998) 54K-60K
2. Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 139 (2000) S115-S119
3. McVeigh J.J., and Lopaschuk G.D. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259 (1990) H1079-H1085
4. Broderick T.L., Quinney H.A., and Lopaschuk G.D. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267 (1992) 3758-3763
5. McCormack J.G., Barr R.L., Wolff A.A., and Lopaschuk G.D. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93 (1996) 135-142
6. Dilsizian V., Bateman T.M., Bergmann S.R., et al. Metabolic imaging with β-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112 (2005) 2169-2174
7. Goldstein R.A., Klein M.S., Welch M.J., and Sobel B.E. External assessment of myocardial metabolism with C-11 palmitate in vivo. J Nucl Med 21 (1980) 342-348
8. Schon H.R., Schelbert H.R., Robinson G., et al. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J 103 (1982) 532-547
9. 123I-phenyl) pentadecanoic acid with serial single-photon emission tomography. Nuklearmedizin 21 (1982) 249-253
10. 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion. J Nucl Med 40 (1999) 821-828
11. Caldwell J.H., Martin G.V., Link J.M., et al. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion. J Nucl Med 31 (1990) 99-105
12. Murray G., Schad N., Ladd W., et al. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 33 (1992) 1269-1277
13. 123I-iodophenylpentadecanoic acid. J Nucl Med 41 (2000) 1299-1307
14. Goodman M.M., Kirsch G., and Knapp F.F. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α- and β-methyl branched fatty acids. J Med Chem 27 (1984) 390-397
15. Knapp F.F., and Kropp J. Iodine 123-labelled fatty acids for myocardial single-photon tomography: current status and future perspectives. Eur J Nucl Med 22 (1995) 361-381
16. Tamaki N., Kawamoto M., Yonekura Y., et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 33 (1992) 659-667
17. Hambye A.S., Vaerenberg M.M., Dobbeleir A.A., et al. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: correlation with contractile response to low-dose dobutamine. J Nucl Med 39 (1998) 1845-1850
18. Kudoh T., Tadamura E., Tamaki N., et al. Iodinated free fatty acid and 201T1 uptake in chronically hypoperfused myocardium: histologic correlation study. J Nucl Med 41 (2000) 293-296
19. Franken P.R., Dendale P., De Geeter F., et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 37 (1996) 718-722
20. 201Tl SPECT images. Eur J Nucl Med 23 (1996) 917-923
21. Hashimoto A., Nakata T., Tsuchihashi K., et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 77 (1996) 25-30
22. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28 (1996) 1328-1428
23. Burt C.W. Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996. Am J Emerg Med 17 (1999) 552-559
24. Brodie B.R., Hansen C., Stuckey T.D., et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 47 (2006) 289-295
25. Udelson J.E., Beshansky J.R., Ballin D.S., et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia; a randomized controlled trial. JAMA 288 (2002) 2693-2700
26. Klocke F.J., Baird M.G., Lorell B.H., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108 (2003) 1404-1418
27. Tatum J.L., Jesse R.L., Kontos M.C., et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 29 (1997) 116-125
28. Kawai Y., Tsukamoto E., Nozaki Y., et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
29. Taegtmeyer H., Goodwin G.W., Doenst T., and Frazier O.H. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 80 (1997) 3A-10A
30. 123I-BMIPP SPECT. Chest 117 (2000) 65-72
31. Seki H., Toyama T., Higuchi K., et al. Prediction of functional improvement of ischemic myocardium with 123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J 69 (2005) 311-319
32. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
33. Al-Khatib S.M., Sanders G.D., Mark D.B., et al. Implantable cardioverter-defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 149 (2005) 1020-1034
34. Solomon S.D., Zelenkofske S., McMurray J.J.V., et al., Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 325 (2004) 2581-2588
35. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
36. Buxton A.E. Sudden death after myocardial infarction-who needs prophylaxis, and when?. N Engl J Med 325 (2004) 2638-2640
37. Stecker E.C., Vickers C., Waltz J., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon sudden unexpected death study. J Am Coll Cardiol 47 (2006) 1161-1166
38. Bolognese L., Carrabba N., Parodi G., et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 109 (2004) 1121-1126
39. Gibson C.M. Has my patient achieved adequate myocardial reperfusion?. Circulation 108 (2003) 504-507
40. Jeremias A., and Gibson C.M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142 (2005) 786-791
41. El Fakhri G., Sitek A., Zimmerman R.E., and Ouyang J. Generalized five-dimensional dynamic and spectral factor analysis. Med Phys 33 (2006) 1016-1024
42. El Fakhri G., Habert M.O., Maksud P., et al. Quantitative simultaneous 99mTc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 33 (2006) 87-92
43. Gibbons R.J., Eckel R.H., Jacobs A.K., et al., American Heart Association Science Advisory and Coordinating Committee. The utilization of cardiac imaging. Circulation 113 (2006) 1715-1716
44. Taegtmeyer H. Metabolism-the lost child of cardiology. J Am Coll Cardiol 36 (2000) 1386-1388
45. Hashimoto A., Nakata T., Nagao K., et al. Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid. J Cardiol 26 (1995) 59-68 Japanese
46. Nishimura T., Nishimura S., Kajiya T., et al. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP and 201Tl myocardial single photon emission computed tomography: a multicenter trial. Ann Nucl Med 12 (1998) 237-248
47. Fujiwara S., Takeishi Y., Atsumi H., et al. Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 5 (1998) 119-127
48. Hambye A.S., Vervaet A., Dobbeleir A., Dendale P., and Franken P. Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarction. Eur J Nucl Med 27 (2000) 1494-1500
49. Akimoto N. Prediction of improvement of left ventricular wall motion in patients with myocardial infarction-by using 99mTc-tetrofosmin and 123I-BMIPP myocardial SPECT at subacute phase. Kaku Igaku 37 (2000) 291-301 Japanese
50. Yasugi N., Koyanagi S., Ohzono K., et al. Comparative study of dobutamine stress echocardiography and dual single-photon emission computed tomography (thallium-201 and I-123 BMIPP) for assessing myocardial viability after acute myocardial infarction. Circ J 66 (2002) 1132-1138
51. Akutsu Y., Kodama Y., Nishimura H., et al. Contractile reserve, thallium-201 reverse redistribution and mismatch between perfusion and metabolism in reperfused infarct-related myocardium with delayed and incomplete functional recovery. Jpn Heart J 45 (2004) 739-748
52. Tani T., Teragaki M., Watanabe H., et al. Detecting viable myocardium and predicting functional improvement: comparisons of positron emission tomography, rest-redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography. Circ J 68 (2004) 950-957